Shivaprakash Gangappa Selected Research

Shivaprakash Gangappa Research Topics

Disease

23	Infections 01/2021 - 04/2002
15	Human Influenza (Influenza) 12/2021 - 10/2008
8	Virus Diseases (Viral Diseases) 01/2021 - 11/2002
6	Influenza in Birds (Avian Flu) 11/2018 - 03/2007
3	Inflammation (Inflammations) 01/2021 - 03/2009
2	Communicable Diseases (Infectious Diseases) 01/2017 - 11/2015
2	Persistent Infection 07/2009 - 04/2002
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Chickenpox 01/2021
1	Measles 01/2021
1	COVID-19 12/2020
1	HIV Infections (HIV Infection) 01/2019
1	Meningococcal Meningitis 01/2017
1	Protein-Energy Malnutrition (Marasmus) 01/2017
1	Neoplasms (Cancer) 10/2016
1	Autoimmune Diseases (Autoimmune Disease) 10/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2012
1	Adenocarcinoma of Lung 04/2012
1	Cytokine Release Syndrome 10/2010
1	Ebola Hemorrhagic Fever 09/2009
1	Herpesviridae Infections (Herpesvirus Infection) 04/2002
1	Latent Infection 04/2002

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 12/2021 - 06/2006
9	Antiviral Agents (Antivirals)IBA 03/2020 - 11/2002
5	Proteins (Proteins, Gene)FDA Link 03/2020 - 04/2002
4	CytokinesIBA 01/2016 - 03/2007
3	EpitopesIBA 01/2021 - 01/2017
3	LigandsIBA 01/2016 - 06/2011
2	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2021 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2021 - 12/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2016
2	AntibodiesIBA 01/2021 - 12/2020
2	AntigensIBA 01/2021 - 12/2014
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2020 - 06/2011
2	Sirolimus (Rapamycin)FDA Link 10/2016 - 07/2009
2	InterferonsIBA 01/2012 - 04/2002
2	Interleukin-6 (Interleukin 6)IBA 10/2010 - 03/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2010 - 03/2007
1	sialic acid receptorIBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	Superoxides (Superoxide)IBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	ProtollinIBA 01/2017
1	Pharmaceutical PreparationsIBA 10/2016
1	NADPH Oxidase 1IBA 01/2016
1	NADPH Oxidase 2IBA 01/2016
1	EnzymesIBA 01/2016
1	Interleukin-7 (Interleukin 7)IBA 01/2016
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016
1	InflammasomesIBA 12/2015
1	SodiumIBA 11/2015
1	SaltsIBA 11/2015
1	Neutralizing AntibodiesIBA 11/2015
1	Nuclear Proteins (Protein, Nuclear)IBA 02/2013
1	Viral ProteinsIBA 04/2012
1	Small Interfering RNA (siRNA)IBA 04/2012
1	Neuraminidase (Sialidase)IBA 04/2012
1	5' Untranslated Regions (5' UTR)IBA 01/2012
1	Complement System Proteins (Complement)IBA 01/2012
1	Complementary RNA (cRNA)IBA 01/2012
1	3' Untranslated Regions (3' UTR)IBA 01/2012
1	Chemokine CCL5IBA 04/2011
1	Calcineurin InhibitorsIBA 10/2010
1	CalcineurinIBA 10/2010
1	Tacrolimus (Prograf)FDA LinkGeneric 10/2010
1	Interferon Type IIBA 06/2009
1	Interferon-betaIBA 06/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2009
1	Attenuated VaccinesIBA 04/2008
1	B7-H1 AntigenIBA 09/2007
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2007
1	Interleukin-1 (Interleukin 1)IBA 03/2007
1	Type I Tumor Necrosis Factor ReceptorsIBA 03/2007
1	Chemokine CCL3IBA 03/2007
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2007
1	CyclinsIBA 04/2002

Therapy/Procedure

2	Therapeutics 01/2016 - 09/2009